Neuropathy and impaired glucose tolerance: an updated review of the evidence
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
There has been considerable interest in the possible association between impaired glucose tolerance (IGT) and neuropathy. A systematic literature search (Medline) and review was here performed. Twenty-three studies were evaluated. Fourteen investigated for the presence of neuropathy in patients with IGT. Nine studied patients with chronic idiopathic axonal polyneuropathy (CIAP), for the prevalence of IGT. The findings suggest that a significant proportion of patients with IGT may have neuropathy, particularly of the small-fibre and painful type. Similarly, a significant percentage of patients without another identifiable cause for painful axonal neuropathy may have IGT. This may however not be applicable to all populations. There are issues relating to the reproducibility, reliability and timing of a single glucose tolerance test (GTT) in establishing a diagnosis of IGT. Furthermore, it is possible neuropathic damage may occur at lower glucose levels than those defining IGT. In conclusion, further prospective long-term study of large IGT cohorts with known prestudy IGT duration is required to confirm and answer the many remaining questions about this presumed association. However, at present time, consideration of IGT as potential cause of painful small-fibre neuropathy appears justified, especially as patients may benefit from dietary and physical exercise interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vascular risk factors and diabetic neuropathy
Tesfaye, S., Chaturvedi, N., Eaton, S. E. M., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., & Fuller, J. H. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032782 · Cited by 1,323
The spectrum of neuropathy in diabetes and impaired glucose tolerance
Sumner, C. J., Sheth, S., Griffin, J. W., Cornblath, D. R., & Polydefkis, M. (2003) · Neurology · doi:10.1212/wnl.60.1.108 · Cited by 708 · cited 1×
“(26) described in 2003, 26 of 58 patients (45%) with neuropathy having IGT on GTT.”
BackgroundLifestyle intervention for pre-diabetic neuropathy
Smith, A. G., Russell, J., Feldman, E. L., Goldstein, J., Peltier, A., Smith, S., Hamwi, J., Pollari, D., Bixby, B., Howard, J., et al. (2006) · Diabetes Care · doi:10.2337/dc06-0224 · Cited by 585
Microvascular complications of impaired glucose tolerance
Singleton, J. R., Smith, A. G., Russell, J. W., & Feldman, E. L. (2003) · Diabetes · doi:10.2337/diabetes.52.12.2867 · Cited by 372
Increased Prevalence of Impaired Glucose Tolerance in Patients With Painful Sensory Neuropathy
Singleton, J. R., Smith, A. G., & Bromberg, M. B. (2001) · Diabetes Care · doi:10.2337/diacare.24.8.1448 · Cited by 364
Painful sensory polyneuropathy associated with impaired glucose tolerance
Singleton, J. R., Smith, A. G., & Bromberg, M. B. (2001) · Muscle & Nerve · doi:10.1002/mus.1136 · Cited by 241
Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy
Smith, A. G., Ramachandran, P., Tripp, S., & Singleton, J. R. (2001) · Neurology · doi:10.1212/wnl.57.9.1701 · Cited by 235 · cited 4×
“However, relevant studies to this current review using skin histology appeared exceptional (13), as were those using Laser Doppler techniques (21).”
BackgroundMethodInfluentialImpaired glucose tolerance and neuropathy
Smith, A. G., & Singleton, J. R. (2008) · The Neurologist · doi:10.1097/nrl.0b013e31815a3956 · Cited by 165 · cited 1×
“In a further review, Smith and Singleton in 2008 reached the conclusion that IGT represents the cause of neuropathy in 40% of undiagnosed cases although stated that the extent to which IGT causes nerve injury, as opposed to being a co-variant with other factors such as the metabolic syndrome, nevertheless remained to…”
BackgroundBalion, C. M., Raina, P. S., Gerstein, H. C., Santaguida, P. L., Morrison, K. M., Booker, L., & Hunt, D. L. (2007) · Clinical Chemical Laboratory Medicine · doi:10.1515/cclm.2007.505 · Cited by 107 · cited 1×
“It is noteworthy that the reproducibility of IGT has been found to be only fair to poor in a systematic review which evaluated the findings of 5 studies (41).”
BackgroundHoffman-Snyder, C., Smith, B. E., Ross, M. A., Hernandez, J., & Bosch, E. P. (2006) · Archives of Neurology · doi:10.1001/archneur.63.8.noc50336 · Cited by 100 · cited 2×
“s (28) retrospective study for its part found a 38% rate of IGT in patients with idiopathic neuropathy, of all types including sensori-motor, pure sensory and smallfibre type.”
Background
Cited by
Pre-Diabetes, Metabolic Syndrome, and Cardiovascular Risk
Grundy, S. M. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.080 · Cited by 627
Hyperglycemia Predicts Persistently Lower Muscle Strength With Aging
Kalyani, R. R., Metter, E. J., Egan, J., Golden, S. H., & Ferrucci, L. (2015) · Diabetes Care · doi:10.2337/dc14-1166 · Cited by 236
Azmi, S., Ferdousi, M., Petropoulos, I. N., Ponirakis, G., Alam, U., Fadavi, H., Asghar, O., Marshall, A., Atkinson, A. J., Jones, W., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2733 · Cited by 148
Metadata
- Authors
- Rajabally, Y. A.
- Venue
- Acta Neurologica Scandinavica
- Publisher
- Hindawi Limited
- Published
- 2010-09-26
- Volume
- 124
- Issue
- 1
- Pages
- 1-8
- ISSN
- 0001-6314 (ISSN-L)
- OpenAlex
- W1522075785
- Cited by
- 34
- References
- 12
- FWCI
- 1.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuropathy and impaired glucose tolerance: an updated review of the evidence. https://app.cochat.ai/papers/10.1111/j.1600-0404.2010.01425.x
- The paper
- Rajabally, Y. A. (2011). Neuropathy and impaired glucose tolerance: an updated review of the evidence. Acta Neurologica Scandinavica. https://doi.org/10.1111/j.1600-0404.2010.01425.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.